Biotage gets new CEO
Tomas Blomquist has been appointed as the new CEO and President of Biotage AB.
Tomas Blomquist, most recently Abbott’s Vice President EMEA Cardimetabolic, will join Biotage on November 6, 2019 and will be responsible for the Biotage Group and its 400 employees. he has a long history in the life sciences industry and has sales and management experience with Alere, Analyticon, Johnson & Johnson and Roche.
DiogenX SA
Adaptimmune
Qiagen NV